Andrew O. Hopper

Andrew O. Hopper, MD is a Professor in the School of Medicine at Loma Linda University, specializing in the Pediatric Neonatology Division. With a medical career spanning several decades since earning his MD in 1976, Dr. Hopper has established himself as a prominent figure in neonatal medicine.

Dr. Hopper's research focuses on critical areas of neonatology including premature infant care, retinopathy of prematurity, and cerebral oximetry monitoring in extremely preterm infants. His work addresses vital aspects of neonatal physiology and clinical interventions that impact survival and long-term outcomes for vulnerable newborns.

His publication record demonstrates consistent scholarly activity, with 87 research outputs documented across his career. The recent publications (2023-2025) reveal his ongoing engagement with cutting-edge neonatal research topics, particularly cerebral monitoring techniques and metabolic studies in premature infants. His work appears in reputable journals including the New England Journal of Medicine and specialized neonatology publications.

Dr. Hopper has participated in significant multicenter clinical trials such as the SafeBoosC-III study, indicating his involvement in large-scale research initiatives that shape neonatal care standards. His professional philosophy emphasizes ethical practice with personal goals centered on 'doing the best you can; doing the right thing' and following the golden rule 'Do unto others as you would have them do unto you.'